These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Suppression of ethanol withdrawal by dopamine. Blum K; Eubanks JD; Wallace JE; Schwertner HA Experientia; 1976 Apr; 32(4):493-5. PubMed ID: 944645 [TBL] [Abstract][Full Text] [Related]
3. [Neuromediator systems of brain cortex and cerebellum under alcohol and morphine withdrawal syndrome conditions]. Lelevich SV Eksp Klin Farmakol; 2012; 75(3):26-30. PubMed ID: 22679750 [TBL] [Abstract][Full Text] [Related]
4. Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms. Ubaldi M; Del Bello F; Domi E; Pigini M; Nasuti C Eur J Pharmacol; 2015 Aug; 760():122-8. PubMed ID: 25895641 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of BR-16A (Mentat), a herbal preparation on alcohol abstinence-induced anxiety and convulsions. Kulkarni SK; Verma A Indian J Exp Biol; 1993 May; 31(5):435-9. PubMed ID: 8359850 [TBL] [Abstract][Full Text] [Related]
6. Use of potentiated preparations to relieve alcohol and opium withdrawal syndromes. Aleksandrova NV; Gofman AG; Krylov EN; Epstein OI Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():163-6. PubMed ID: 12949688 [TBL] [Abstract][Full Text] [Related]
7. Absence of an effect of naloxone on ethanol intoxication and withdrawal reactions. Hemmingsen R; Sørensen SC Acta Pharmacol Toxicol (Copenh); 1980 Jan; 46(1):62-5. PubMed ID: 7189080 [TBL] [Abstract][Full Text] [Related]
8. Effective Reduction of Acute Ethanol Withdrawal by the Tetracycline Derivative, Tigecycline, in Female and Male DBA/2J Mice. Martinez JM; Groot JA; Curtis DC; Allison CL; Marquardt PC; Holmes AN; Edwards DS; Trotter DR; Syapin PJ; Finn DA; Bergeson SE Alcohol Clin Exp Res; 2016 Dec; 40(12):2499-2505. PubMed ID: 27862011 [TBL] [Abstract][Full Text] [Related]
9. The effects of drugs on barbiturate withdrawal convulsions in the rat. Norton PR J Pharm Pharmacol; 1970 Oct; 22(10):763-6. PubMed ID: 4394782 [No Abstract] [Full Text] [Related]
10. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal. Beadles-Bohling AS; Wiren KM Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153 [TBL] [Abstract][Full Text] [Related]
11. Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal. Riegle MA; Masicampo ML; Shan HQ; Xu V; Godwin DW Alcohol Alcohol; 2015 Sep; 50(5):501-8. PubMed ID: 25870316 [TBL] [Abstract][Full Text] [Related]
12. Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). Finn DA; Snelling C; Fretwell AM; Tanchuck MA; Underwood L; Cole M; Crabbe JC; Roberts AJ Alcohol Clin Exp Res; 2007 Jun; 31(6):939-49. PubMed ID: 17403068 [TBL] [Abstract][Full Text] [Related]
13. [Benzodiazepines in the treatment of alcoholism]. Ades J; Rodière C Encephale; 1983; 9(4 Suppl 2):293B-298B. PubMed ID: 6373235 [TBL] [Abstract][Full Text] [Related]
14. [Study on the detoxification of alcohol extracts from orientvine and its effective component on withdrawal syndromes of morphine]. Zhang GM; Mo ZX; Wang CY Zhong Yao Cai; 2009 Sep; 32(9):1414-8. PubMed ID: 20034221 [TBL] [Abstract][Full Text] [Related]
15. Effects of lorazepam treatment for multiple ethanol withdrawals in mice. Becker HC; Veatch LM Alcohol Clin Exp Res; 2002 Mar; 26(3):371-80. PubMed ID: 11923591 [TBL] [Abstract][Full Text] [Related]
16. [The role of dopamine neurotransmission on the development of ethanol dependence and course of abstinence syndrome]. Samochowiec J Ann Acad Med Stetin; 1994; 40():195-217. PubMed ID: 7503446 [TBL] [Abstract][Full Text] [Related]
17. Role of dopamine D3 receptors in basal nociception regulation and in morphine-induced tolerance and withdrawal. Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB Brain Res; 2012 Jan; 1433():80-4. PubMed ID: 22154407 [TBL] [Abstract][Full Text] [Related]
18. Chronic ethanol differentially alters susceptibility to chemically induced convulsions in withdrawal seizure-prone and -resistant mice. Finn DA; Crabbe JC J Pharmacol Exp Ther; 1999 Feb; 288(2):782-90. PubMed ID: 9918589 [TBL] [Abstract][Full Text] [Related]